Technical analysis of Vericel Corporation (VCEL): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Vericel Corporation operates as a biopharmaceutical firm that has reached the commercialization phase, specializing in the research, development, production, and distribution of cell-based treatments. Its primary therapeutic areas are sports medicine and critical burn care across the United States.
Price Performance
| 1 month | +0.90% |
| 3 months | -10.69% |
| Year-to-date | +12.50% |
| 1 year | +10.35% |
| 3 years | +9.90% |
| 5 years | -16.75% |
| 10 years | +1784.19% |
52-Week Range
| 52-week High | $49.32 |
| 52-week Low | $28.95 |
| Avg Volume (90d) | 543K |
Technical Indicators
| SMA 50 | $40.54 |
| SMA 200 | $38.66 |
| Beta | 1.21 |
| 30-day Volatility (annualised) | 37.9% |
| Price vs SMA 50 | -0.1% |
| Price vs SMA 200 | +4.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $36.01 | |
| 2026-01 | $35.98 | -0.1% |
| 2026-02 | $35.68 | -0.8% |
| 2026-03 | $32.17 | -9.8% |
| 2026-04 | $34.73 | +8.0% |
| 2026-05 | $33.33 | -4.0% |
| 2026-06 | $44.49 | +33.5% |
| 2026-07 | $45.96 | +3.3% |
| 2026-08 | $39.90 | -13.2% |
| 2026-09 | $40.14 | +0.6% |
| 2026-10 | $40.26 | +0.3% |
| 2026-11 | $40.51 | +0.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-05 | $0.06 | $78M |
| 2026-07-30 | $-0.03 | $73M |
| 2026-05-07 | $-0.15 | $64M |
| 2026-02-26 | $0.45 | $91M |
| 2025-11-06 | $-0.02 | $93M |
| 2025-07-31 | $-0.04 | $65M |
| 2025-05-08 | $-0.09 | $65M |
Price
| Price | $40.51 (closing price, November 2, 2026) |
| Market Cap | $2.1B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 86.60 |
| Price / Book | 5.57 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.25 |
| Current Ratio | 5.04 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 8.25 |